$AMWL

American Well Corp

Amwell provides a digital care platform and related services to health systems, health plans, employers, government entities and healthcare innovators. Its Amwell Platform supports hybrid care across in-person, virtual and automated settings, with applications including virtual primary and urgent care, behavioral health, chronic condition management, specialty consultations and virtual nursing. The company also offers Carepoint devices, partner programs, implementation and integration services, and patient and provider engagement services. Through Amwell Medical Group, a nationwide network of clinicians, it provides clinical staffing to supplement clients’ own care capabilities. Amwell primarily earns money from recurring subscriptions to its platform, with additional sales of configurable modules, partner programs, devices and related services. It also sells clinical services on a fee-for-service basis through the platform and its direct-to-consumer app. Amwell is headquartered in Boston, Massachusetts.

No enriched coverage for $AMWL in the last 7 days.

No SEC Form 4 filings for $AMWL in the last 30 days.

See all $AMWL insider activity →
Low

Amwell makes grant to new employees under inducement plan

Amwell granted 5,761 RSUs to two new employees, vesting over three years. The awards were made under its Inducement Plan and may slightly dilute existing shares. The company's stock has shown varied performance post-headlines.

Key facts: American Well Targets Rise; Hold Consensus, 2% Upside

Analysts at TD Cowen and Stifel maintained Hold ratings on American Well (AMWL) but raised their price targets to $13 and $12, respectively. The average 12-month price target increased to $13, suggesting 2% upside from the Nov. 3 close. The consensus remains Hold with one Buy, seven Holds, and no Sells.

AMWL sentiment & insider activity

Recent AMWL coverage spans financial news, earnings and insider activity.

What's driving AMWL

AlphAI scores every news story that mentions AMWL with an AI model for sentiment and relevance, and aggregates insider trades from American Well Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AMWL

Score

What American Well (AMWL) Said on Its Q3 Earnings Call

Amwell (AMWL) reported Q3 earnings with virtual primary care visits up 41% YoY, but total platform visits down 30.5%. Gross profit was $26M with a 53% margin. Q4 revenue is forecasted at $48M-$50M, with adjusted EBITDA expected to break even or turn positive. The company raised its full-year 2026 outlook, now expecting revenue of $204M-$206M and a reduced adjusted EBITDA loss. Amwell also discussed potential government contracts, including a nonbinding letter of intent from the VA.

$AMWLHighEarnings

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026 BOSTON, November 3 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30,

Related tickers